Citation 1: Dai C, Ma Y, Zhao Z, et al. Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother. 2008;52(11):3967-72. Published 2008 Nov. doi:10.1128/AAC.00542-08
Citation 2: Ruiming Z, Yibao M, Yawen H, et al. Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components. BMC Genomics. 2010;11:452. Published 2010 Jul 28. doi:10.1186/1471-2164-11-452
Citation 3: Li Q, Zhao Z, Zhou D, et al. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Peptides. 2011;32(7):1518-25. Published 2011 Jul. doi:10.1016/j.peptides.2011.05.015
Citation 4: Zhao Z, Hong W, Zeng Z, et al. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo. J Biol Chem. 2012;287(36):30181-90. Published 2012 Aug 31. doi:10.1074/jbc.M112.370312
Citation 5: Chen Y, Cao L, Zhong M, et al. Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One. 2012;7(4):e34947. Published 2012. doi:10.1371/journal.pone.0034947
Citation 6: Almaaytah A, Albalas Q, Albalas Q. Scorpion venom peptides with no disulfide bridges: a review. Peptides. 2014;51:35-45. Published 2014 Jan. doi:10.1016/j.peptides.2013.10.021